The Effect Of Lidocaine And Magnesium Sulfate On Pain Of Interavenouse Etomidate
Phase 2
- Conditions
- pain.Analgesic, antipyretic and anti-inflammatory drug, unspecified
- Registration Number
- IRCT2014121420304N1
- Lead Sponsor
- Vice chancellor For Research Of Ahvaz Jondishapour University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 99
Inclusion Criteria
Age range 18-60; Patients undergoing surgery with The anesthetic etomidate
except for cesarean section. Exclusion criteria: Neuromuscular diseases; Heart disease; Epilepsy; pregnancy; Receiving pain medications in twenty-four hours before surgery; Thrombophlebitis; Neurological and psychiatric disorders.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain. Timepoint: After injection of etomidate and during twenty-four hours after surgery. Method of measurement: 4 point Ambesh scal.
- Secondary Outcome Measures
Name Time Method